Mobile app for heart failure management in Berlin and Brandenburg
Mobile and Digital Application in Heart Failure Networks Berlin/Brandenburg
NA · German Heart Institute · NCT05422859
This study is testing a mobile app for people with heart failure in Berlin and Brandenburg to see if it can help improve their quality of life and manage their symptoms better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | German Heart Institute (other) |
| Locations | 3 sites (Berlin, Deutschland and 2 other locations) |
| Trial ID | NCT05422859 on ClinicalTrials.gov |
What this trial studies
The MobiDig trial evaluates a mobile phone application designed for patients with heart failure, focusing on secondary prevention and rehabilitation. Conducted in certified Heart Failure Unit centers in Berlin and Brandenburg, the study aims to assess the app's impact on quality of life, symptoms, and disease progression. Additionally, it will analyze user acceptance, adherence, and the potential for long-term integration into national heart failure networks.
Who should consider this trial
Good fit: Ideal candidates include individuals with a confirmed diagnosis of heart failure who are being treated at certified Heart Failure Unit centers in Berlin or Brandenburg.
Not a fit: Patients with conditions that impair their ability to understand the study or those who do not speak German may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the management and quality of life for patients with heart failure through improved digital support.
How similar studies have performed: While the use of mobile applications in healthcare is growing, this specific approach is novel and has not been extensively tested in the context of heart failure management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of heart failure * Treatment in a certified Heart Failure Unit center in Berlin or Brandenburg * Written informed consent of the participants * User of a mobile device with an iOS operating system Exclusion Criteria: * Addiction or other illnesses that do not allow the participants to assess the nature and scope as well as possible consequences of participation or its scientific evaluation * insufficient knowledge of the German language, which is necessary to use the application
Where this trial is running
Berlin, Deutschland and 2 other locations
- Deutsches Herzzentrum der Charité - Universitätsmedizin Berlin — Berlin, Deutschland, Germany (RECRUITING)
- Charité - Universitätsmedizin Berlin: Campus Virchow-Klinikum — Berlin, Germany (RECRUITING)
- Herzzentrum Berlin — Bernau, Germany (ACTIVE_NOT_RECRUITING)
Study contacts
- Study coordinator: Isabell A Just, Dr.
- Email: ijust@dhzb.de
- Phone: 00493045932025
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Heart Failure